Patent · US Active

Systems and methods for modulating CRISPR activity

US11884918B2 · kind B2 · utility

0Cited by
4References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2021
Grant dateJan 30, 2024
Priority date
Expiry dateJul 23, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/53
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are polynucleotides comprising sequence configured to bind to a CRISPR effector protein. Modulation of one or more modifications of the polynucleotides can be used to tune the activity of CRISPR effector proteins complexed with the polynucleotides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.